Oxford Nanopore Technologies (LON:ONT) Earns Outperform Rating from Royal Bank of Canada – MarketBeat
Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:
Oxford Nanopore Technologies (LON:ONT – Get Rating)‘s stock had its “outperform” rating restated by analysts at Royal Bank of Canada in a note issued to investors on Wednesday, MarketBeat.com reports. They presently have a GBX 400 ($4.84) price target on the stock. Royal Bank of Canada’s price target would suggest a potential upside of 29.03% from the company’s current price.
Several other research firms also recently commented on ONT. Barclays dropped their target price on Oxford Nanopore Technologies from GBX 700 ($8.48) to GBX 500 ($6.05) and set an “overweight” rating on the stock in a report on Tuesday, May 31st. JPMorgan Chase & Co. dropped their target price on Oxford Nanopore Technologies from GBX 790 ($9.57) to GBX 710 ($8.60) and set an “overweight” rating on the stock in a report on Tuesday, March 29th. Finally, Berenberg Bank reissued a “buy” rating and issued a GBX 671 ($8.13) target price on shares of Oxford Nanopore Technologies in a report on Wednesday.
Oxford Nanopore Technologies stock traded up GBX 35 ($0.42) during mid-day trading on Wednesday, hitting GBX 310 ($3.75). The company had a trading volume of 2,646,657 shares, compared to its average volume of 1,668,368. The company has a quick ratio of 5.23, a current ratio of 7.15 and a debt-to-equity ratio of 3.52. The business has a 50 day simple moving average of GBX 305.91. Oxford Nanopore Technologies has a 12 month low of GBX 239 ($2.89) and a 12 month high of GBX 736 ($8.91). The company has a market capitalization of £2.55 billion and a P/E ratio of -13.54.
What’s the highest-yielding stock you’ve ever owned? The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%!
When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate.
In other Oxford Nanopore Technologies news, insider Sarah Gordon Wild purchased 14,778 shares of the stock in a transaction dated Monday, May 30th. The shares were purchased at an average cost of GBX 337 ($4.08) per share, with a total value of £49,801.86 ($60,307.41). Also, insider Adrian Nevil Hennah bought 14,125 shares of the stock in a transaction on Tuesday, April 12th. The stock was purchased at an average cost of GBX 356 ($4.31) per share, for a total transaction of £50,285 ($60,892.47). Over the last ninety days, insiders have bought 29,002 shares of company stock worth $10,038,797.
Oxford Nanopore Technologies Company Profile (Get Rating)
Oxford Nanopore Technologies Limited develops and commercializes a technology platform using nanopore-based sensing for the analysis of various types of molecules. The company offers MinION, a portable device for deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) sequencing; GridION, a self-contained benchtop device for running and analyzing up to five MinION or Flongle flow cells; Flongle, an adapter for use in MinION or GridION devices to attach a Flongle flow cell; PromethION 24 and PromethION 48 benchtop nanopore-based sequencers for multiple users to deliver multi-sample and multi-experiment sequencing results; and VolTRAX, an alternative lab equipment.
Featured Articles
- Recession Resistant Grocery Outlet Holding Corp Quietly Sets New High
- It’s Not Too Late For These Undervalued Energy Stocks
- Three Cheap Stocks That Just Got Upgraded
- Get Defensive With These Three Upgrades
- 3 Home Improvement Stocks That Can Renovate Your Portfolio
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Oxford Nanopore Technologies, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Oxford Nanopore Technologies wasn’t on the list.
While Oxford Nanopore Technologies currently has a “Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.
View The 5 Stocks Here
Complete the form below to receive the latest headlines and analysts’ recommendations for your stocks with our free daily email newsletter:
Today’s interview is a little different, in that you get a LOT of market perspective from someone who’s been analyzing stocks from the ground up, for more than three decades. In this conversation, Kate chats with Nancy Zambell, the chief analyst for the Cabot Money Club Letter – and Nancy has a really deep and varied background in the financial industry – as she mentions in this interview, she’s been a banker, real estate professional, and a stock market analyst.
Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat’s trending stocks report.
Identify stocks that meet your criteria using seven unique stock screeners. See what’s happening in the market right now with MarketBeat’s real-time news feed. Export data to Excel for your own analysis.
MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.
Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.
Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.
As Featured By:
MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.
Twitter Facebook StockTwits Financial Juice YouTube
© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.
Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds
© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided ‘as-is’ and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.